These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7232658)

  • 1. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an intrastriatal GABA control on motor activity arising from dopaminergic hyperfuction in the striatum.
    Scarnati E; Forchetti C; Ruggieri S; Agnoli A
    Acta Neurol (Napoli); 1978 Aug; 33(4):304-313. PubMed ID: 742442
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic studies of tardive dyskinesia.
    Chase TN; Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 24():457-61. PubMed ID: 7405673
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia.
    Scheel-Krüger J; Arnt J
    Psychopharmacology Suppl; 1985; 2():46-57. PubMed ID: 2987907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"?
    Kapit RM
    Med Hypotheses; 1977; 3(5):207-10. PubMed ID: 904502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 10. GABA dysfunction in the pathophysiology of tardive dyskinesia.
    Tamminga CA; Thaker GK; Chase TN
    Psychopharmacology Suppl; 1985; 2():122-7. PubMed ID: 2987903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Late dyskinesia: experimental models, paradoxes and deductions].
    Vamvakidès A
    Agressologie; 1987 Sep; 28(8):827-30. PubMed ID: 2827536
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV; Lohr JB; Clark K; Wyatt RJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 16. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECT and tardive dyskinesia.
    Lerer B
    J Clin Psychiatry; 1984 Apr; 45(4):188. PubMed ID: 6715296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tardive dyskinesia--research results and preventive measures].
    Gunne LM
    Lakartidningen; 1987 Apr; 84(17):1458-63. PubMed ID: 3586787
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptors and locomotor responses: molecular aspects.
    Sealfon SC
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S12-9; discussion S19-21. PubMed ID: 10762128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA; Smith RC; Pandey G; Frohman LA; Davis JM
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.